Propanc Biopharma (PPCB) Short Interest Ratio & Short Volume

$0.0005

0.00 (0.00%)

(As of 09/6/2024 ET)

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Propanc Biopharma Short Interest Data

Propanc Biopharma (PPCB) has a short interest of 2.89 million shares. This marks a 1,783.98% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 14.61 million shares to cover all short positions.

Current Short Interest: 2,893,800 shares
Previous Short Interest: 153,600 shares
Change Vs. Previous Month: +1,783.98%
Dollar Volume Sold Short: $1,157.52
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: August 15, 2024

Outstanding Shares: 167,979,000 shares
Percentage of Shares Shorted: 1.72%
Today's Trading Volume: 1,614,000 shares
Average Trading Volume: 14,614,755 shares
Today's Volume Vs. Average: 11%

Short Selling Propanc Biopharma?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Propanc Biopharma and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

PPCB Short Interest Over Time

PPCB Days to Cover Over Time

PPCB Percentage of Float Shorted Over Time

Ad Porter & Company

War on Elon Escalates…

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Propanc Biopharma Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/15/2024	2,893,800 shares	$1,157.52	+1,784.0%	N/A	0	$0.00
7/31/2024	153,600 shares	$122.88	No Change	N/A	0	$0.00
6/30/2024	31,500 shares	$39.38	-57.2%	N/A	0	$0.00
6/15/2024	73,600 shares	$117.76	No Change	N/A	0	$0.00
5/15/2024	77,600 shares	$54.32	+9.8%	N/A	0	$0.00
4/30/2024	70,700 shares	$70.70	No Change	N/A	0	$0.00
Get the Latest News and Ratings for PPCB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Propanc Biopharma and its competitors with MarketBeat's FREE daily newsletter.
3/31/2024	6,200 shares	$19.84	No Change	N/A	0	$0.00
2/29/2024	127,100 shares	$432.14	+355.6%	N/A	0	$0.00
2/15/2024	27,900 shares	$131.13	+39.5%	N/A	0	$0.00
1/15/2024	12,000 shares	$120.00	+11,900.0%	N/A	0	$0.01
12/31/2023	100 shares	$1.20	-99.8%	N/A	0	$0.01
12/15/2023	59,300 shares	$646.37	+352.7%	N/A	0	$0.01
11/30/2023	13,100 shares	$111.35	+23.6%	N/A	0	$0.01
11/15/2023	10,600 shares	$140.98	-74.9%	N/A	0	$0.01
10/31/2023	42,200 shares	$481.08	+20.6%	N/A	0.1	$0.01
10/15/2023	35,000 shares	$560.00	+18.2%	N/A	0	$0.02
9/30/2023	29,600 shares	$722.24	+179.3%	N/A	0.1	$0.02
9/15/2023	10,600 shares	$318.00	-64.7%	N/A	0	$0.03
8/31/2023	30,000 shares	$1,647.00	No Change	N/A	0	$0.05
7/31/2023	34,000 shares	$2,764.20	-5.0%	N/A	0	$0.08
7/15/2023	35,800 shares	$3,377.73	+21.8%	N/A	0	$0.09
6/30/2023	29,400 shares	$3,969.00	No Change	N/A	0	$0.14
5/15/2023	310,100 shares	$62,020.00	+310,000.0%	N/A	0	$0.20
4/30/2023	100 shares	$0.03	-99.5%	N/A	0	$0.00
4/15/2023	18,100 shares	$5.43	-90.4%	N/A	0	$0.00
3/31/2023	188,600 shares	$94.30	+887.4%	N/A	0	$0.00
3/15/2023	19,100 shares	$11.46	-39.2%	N/A	0	$0.00
2/28/2023	31,400 shares	$21.98	-7.9%	N/A	0	$0.00
2/15/2023	34,100 shares	$10.23	-76.3%	N/A	0	$0.00
1/31/2023	144,000 shares	$57.60	-28.0%	N/A	0	$0.00
1/15/2023	200,100 shares	$100.05	+200,000.0%	N/A	0	$0.00
12/30/2022	100 shares	$0.06	-99.8%	N/A	0	$0.00
12/15/2022	55,100 shares	$33.06	-90.3%	N/A	0	$0.00
11/30/2022	565,200 shares	$395.64	+1,025.9%	N/A	0	$0.00
11/15/2022	50,200 shares	$40.16	-49.9%	N/A	0	$0.00
10/31/2022	100,200 shares	$100.20	+57.8%	N/A	0	$0.00
10/15/2022	63,500 shares	$76.20	-30.6%	N/A	0	$0.00
9/30/2022	91,500 shares	$109.80	+45,650.0%	N/A	0	$0.00
9/15/2022	200 shares	$0.34	-99.3%	N/A	0	$0.00
8/31/2022	28,500 shares	$54.15	-78.2%	N/A	0	$0.00
Biden's Successor: The Radical Threat to YOUR Savings! (Ad) Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL. >> Get Your FREE Wealth Protection Guide <<
8/15/2022	130,800 shares	$300.84	+8.0%	N/A	0	$0.00
7/31/2022	121,100 shares	$399.63	-47.4%	N/A	0	$0.00
7/15/2022	230,000 shares	$575.00	+37.6%	N/A	0	$0.00
6/30/2022	167,200 shares	$618.64	+113.3%	N/A	0	$0.00
6/15/2022	78,400 shares	$227.36	+27.7%	N/A	0	$0.00
5/31/2022	61,400 shares	$466.64	+1,103.9%	N/A	0	$0.01
5/15/2022	5,100 shares	$42.02	-70.5%	N/A	0	$0.01
4/30/2022	17,300 shares	$193.76	-94.8%	N/A	0	$0.01
4/15/2022	331,900 shares	$3,949.61	+824.5%	N/A	0.1	$0.01
3/31/2022	35,900 shares	$560.04	+32.0%	N/A	0	$0.02
3/15/2022	27,200 shares	$367.20	-3.9%	N/A	0	$0.01
2/28/2022	28,300 shares	$478.41	No Change	N/A	0	$0.02
1/31/2022	20,400 shares	$393.72	No Change	N/A	0	$0.02
12/31/2021	3,400 shares	$149.60	-83.2%	N/A	0	$0.04
12/15/2021	20,200 shares	$466.62	No Change	N/A	0	$0.02
11/15/2021	3,800 shares	$114.00	+11.8%	N/A	0	$0.03
10/29/2021	3,400 shares	$99.28	+209.1%	N/A	0	$0.03
10/15/2021	1,100 shares	$30.58	-94.8%	N/A	0	$0.03
9/30/2021	21,100 shares	$548.60	No Change	N/A	0	$0.03
8/31/2021	25,000 shares	$1,182.50	No Change	N/A	0	$0.05
7/30/2021	16,600 shares	$595.94	+5.7%	N/A	0	$0.04
7/15/2021	15,700 shares	$703.36	+17.2%	N/A	0	$0.04
6/30/2021	13,400 shares	$692.78	-41.7%	N/A	0	$0.05
6/15/2021	23,000 shares	$1,817.00	-60.8%	N/A	0	$0.08
5/28/2021	58,600 shares	$4,688.00	+4,783.3%	N/A	0.1	$0.08
5/14/2021	1,200 shares	$156.00	-75.0%	N/A	0	$0.13
4/30/2021	4,800 shares	$1,034.40	+269.2%	N/A	0.1	$0.22
4/15/2021	1,300 shares	$273.00	-74.0%	N/A	0	$0.21
3/31/2021	5,000 shares	$1,252.00	-27.5%	N/A	0	$0.25
3/15/2021	6,900 shares	$3,105.00	-60.1%	N/A	0.1	$0.45
2/26/2021	17,300 shares	$5,017.00	-8.0%	N/A	0.1	$0.29
2/12/2021	18,800 shares	$8,084.00	+2,250.0%	N/A	0	$0.43
1/29/2021	800 shares	$332.08	-75.8%	N/A	0	$0.42
12/31/2020	2,000 shares	$620.00	No Change	N/A	0	$0.31
10/30/2020	100 shares	$0.17	No Change	N/A	0	$0.00
9/30/2020	84,100 shares	$159.79	+188.0%	N/A	0	$0.00
9/15/2020	29,200 shares	$52.56	+2,820.0%	N/A	0	$0.00
8/31/2020	1,000 shares	$2.40	No Change	N/A	0	$0.00
7/15/2020	12,900 shares	$34.83	No Change	N/A	0	$0.00
5/15/2020	13,700 shares	$164.40	-74.6%	N/A	0	$0.01
4/30/2020	53,900 shares	$695.31	+241.1%	N/A	0	$0.01
4/15/2020	15,800 shares	$292.30	-60.4%	N/A	0	$0.02
3/31/2020	39,900 shares	$1,200.99	+405.1%	N/A	0	$0.03
3/13/2020	7,900 shares	$395.00	-70.3%	N/A	0	$0.05
2/28/2020	26,600 shares	$1,542.80	+78.5%	N/A	0	$0.06
2/14/2020	14,900 shares	$1,341.00	-38.7%	N/A	0	$0.09
1/31/2020	24,300 shares	$4,250.07	+67.6%	N/A	0	$0.17
1/15/2020	14,500 shares	$3,045.00	-27.1%	N/A	0	$0.21
12/31/2019	19,900 shares	$2,883.51	+729.2%	N/A	0.2	$0.14

PPCB Short Interest - Frequently Asked Questions

What is Propanc Biopharma's current short interest?: Short interest is the volume of Propanc Biopharma shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 2,893,800 shares of PPCB short. Learn More on Propanc Biopharma's current short interest.
Is Propanc Biopharma's short interest increasing or decreasing?: Propanc Biopharma saw a increase in short interest during the month of August. As of August 15th, there was short interest totaling 2,893,800 shares, an increase of 1,784.0% from the previous total of 153,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does Propanc Biopharma's short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Propanc Biopharma: NovAccess Global Inc. (0.01%), TRACON Pharmaceuticals, Inc. (6.64%), China SXT Pharmaceuticals, Inc. (1.17%), Akanda Corp. (4.05%), SciSparc Ltd. (21.51%), eFFECTOR Therapeutics, Inc. (16.84%), Vaxxinity, Inc. (3.61%), Smart for Life, Inc. (27.53%), Lucy Scientific Discovery Inc. (0.24%), Emmaus Life Sciences, Inc. (0.00%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.

What does it mean to sell short Propanc Biopharma stock?: Short selling PPCB is an investing strategy that aims to generate trading profit from Propanc Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Propanc Biopharma?: A short squeeze for Propanc Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPCB, which in turn drives the price of the stock up even further.
How often is Propanc Biopharma's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPCB, twice per month. The most recent reporting period available is August, 15 2024.